Task: Answer the multiple-choice question.
Question: Which compound exhibits a 13.553\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a Cc1ccc(SC[C@H](Cc2ccccc2)N2CCN(CCc3ccccc3)CCC2=O)cc1
b Nc1c(Cl)cc(C2=NCCn3nc4ccccc4c32)cc1Cl
c CCC(=O)n1nc(-c2ccc(Cl)cc2)nc1SC
d Cl.N=c1n(CCO)c2ccccc2n1Cc1ccc(Cl)cc1
e CCCNC(=O)COc1ncnc2sccc12
Answer: b. Nc1c(Cl)cc(C2=NCCn3nc4ccccc4c32)cc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Nc1c(Cl)cc(C2=NCCn3nc4ccccc4c32)cc1Cl
Nc1c(Cl)cc(C2=NCCn3nc4ccccc4c32)cc1Cl
2,6-dichloro-4-(3,4-dihydropyrazino[1,2-b]indazol-1-yl)aniline